Results for "pain relief"

Walgreens Ear Pain Relief and Ear Ache Drops

January 29th, 2015

January 2015: A federal judge granted the parties’ joint motion for dismissal. The reasons for the dismissal have not yet been disclosed. February 2014: A false advertising class-action lawsuit alleging that Walgreens misleadingly labels its Ear Pain Relief and Ear Ache Drops (a homeopathic medicine) was transferred from state court to federal court. The complaint,


Heel, Inc.’s Pain Relief Products

June 30th, 2014

March 2014: A federal judge approved the settlement to this class-action lawsuit against Heel, Inc. October 2013: A federal judge preliminarily approved a $1 million settlement of a class-action lawsuit filed against Heel, Inc. The complaint, filed in December 2012, claims that the company falsely advertised the characteristics, benefits, and abilities of its homeopathic products,


Excedrin Migraine Pain Relief

August 21st, 2013

A reader submitted a tip concerning the pricing of Excedrin Migraine Pain Reliever versus Excedrin Extra Strength Pain Reliever.


Nerve Pain Away

August 13th, 2018

Homeopathic spray becomes the first to adopt disclosure admitting lack of scientific evidence.


“Kids Relief” Products

June 6th, 2018

May 2016: The case was voluntarily dismissed , the reasons for which have not been disclosed. December 2013: The lawsuit filed in Florida state court was transferred to federal court. (Medina et al v. HomeoLab U.S.A., Inc., Case No. 13-cv-62650, S. D. FL.). November 2013: The same named plaintiffs filed a class-action lawsuit bringing similar


CVS Flu Relief

March 4th, 2016

In February 2016, a class-action lawsuit was filed against CVS for allegedly deceptively representing that CVS Flu Relief “[t]emporarily relieves flu-like symptoms” and “reduces the duration & severity of flu-like symptoms such as fever, aches, pains, & chills” when, in reality, the product does not and cannot provide such relief because it is a “sugar


Glucosamine Settlement Offers Little Relief According to Ad Watchdog TINA.org

November 19th, 2014

Supplement Deceptively Marketed to Consumers Nationwide MADISON, CONN., November 19, 2014 — Three of the nation’s largest retailers, Walmart, Supervalu, and Walgreens, are misleading consumers through the promotion and labeling of the popular joint pain remedy, glucosamine, according to a class-action lawsuit that is reaching settlement. The deal? One million dollars will be divided among


Aspercreme

February 4th, 2019

TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.


KT Tape

August 15th, 2018

July 2018: An objector filed a Notice of Appeal regarding the final approval of the settlement. The next day, the objector voluntarily dismissed the appeal, the reasons for which have not been disclosed. June 2018: A federal judge granted final approval of the settlement agreement. November 2017: A federal judge granted preliminary approval of the


Airplus Shoe Insoles

March 20th, 2018

NAD and maker of Airplus shoe insoles get off on the wrong foot over health-related claims.


Tommie Copper’s “Copper-Infused” Athletic Apparel

March 1st, 2018

December 2017: A federal judge granted preliminary approval of a proposed settlement agreement. According to its terms, class members may choose to get either a cash refund or a credit to apply toward future online purchases. Class members with proof of purchase may get either $10 in cash or a $14 credit for each product


Tommie Copper Athletic Compression Apparel and Accessories

January 9th, 2018

December 2017: A federal judge preliminarily approved a settlement agreement that would resolve this consolidated class action, as well as another similar case, Herst v. Tommie Copper. According to the settlement terms, class members may receive a cash award or choose to apply their award to a future purchase on the Tommie Copper website. Class



Back to Top ↑